Privium Fund Management’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$316K	Hold	134,900	–	–	0.07%	49
2025 Q1	$188K	Hold	134,900	–	–	0.05%	53
2024 Q4	$233K	Buy	134,900 +14,900	+12%	+$25.8K	0.05%	56
2024 Q3	$241K	Buy	120,000 +21,500	+22%	+$43.2K	0.06%	71
2024 Q2	$213K	Buy	+98,500	New	+$213K	0.05%	88